Novel pancreatic cancer treatment combining immune suppression mechanism and autophagy induction virus therapy
Project/Area Number |
16K15623
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Digestive surgery
|
Research Institution | Wakayama Medical University |
Principal Investigator |
Hiroki Yamaue 和歌山県立医科大学, 医学部, 教授 (20191190)
|
Co-Investigator(Kenkyū-buntansha) |
中森 幹人 和歌山県立医科大学, 医学部, 准教授 (10322372)
川井 学 和歌山県立医科大学, 医学部, 准教授 (40398459)
尾島 敏康 和歌山県立医科大学, 医学部, 講師 (60448785)
廣野 誠子 和歌山県立医科大学, 医学部, 講師 (60468288)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2018: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Keywords | iPS細胞 / 樹状細胞 / 膵癌 / WT1 / 癌ワクチン / 免疫遺伝子治療 / 免疫療法 / ウイルス療法 / 抗がんウイルス |
Outline of Final Research Achievements |
We investigated whether genetically modified human induced pluripotent stem cell (iPSC)-derived dendritic cells (hiPSDCs) expressing WT1 could induce WT1-specific cytotoxic T cells in pancreatic cancer patients. We differentiated hiPSDCs from iPSCs of three pancreatic cancer patients and transduced the WT1 cDNA into hiPSDCs. The surface marker expression, cytokine secretion and migratory capacity of hiPSDCs were equivalent in healthy donors. After three cycles of stimulation of autologous peripheral blood mononuclear cells by genetically modified hiPSDCs, cytotoxicity was assessed using 51Cr release assay. The cytotoxic T cells induced by hiPSDCs-WT1 exhibited WT1-specific cytotoxic activity against the target cells expressing WT1. Genetically modified iPSDCs expressing WT1 is a promising tool for clinical application on vaccine therapy against pancreatic cancer patients.
|
Academic Significance and Societal Importance of the Research Achievements |
膵癌は5年生存率が10%以下と難治癌であることは周知の事実である.私達は,以前より膵癌に対する癌ワクチン療法の基礎研究を行ってきた.今回,膵癌患者においてiPS細胞由来樹状細胞を誘導し,WT1遺伝子を導入し,CTLを誘導した.CTLはWT1発現腫瘍細胞を特異的に攻撃することを確認した.現在臨床試験に向けてさらなる検討を行っている.本研究が臨床応用されれば,世界初のiPS細胞を用いた膵癌ワクチン療法となり,難治癌で苦しむ患者さんに希望を与えるとともに,現在停滞している日本の癌遺伝子免疫治療においてブレークスルーとなる.
|
Report
(4 results)
Research Products
(49 results)
-
-
[Journal Article] Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients.2019
Author(s)
Aoki S, Motoi F, Murakami Y, Sho M, Satoi S, Honda G, Uemura K, Okada KI, Matsumoto I, Nagai M, Yanagimoto H, Kurata M, Fukumoto T, Mizuma M, Yamaue H, Unno M; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS).
-
Journal Title
BMC Cancer.
Volume: 19
Issue: 1
Pages: 252-252
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Journal Article] Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery.2019
Author(s)
Nagakawa Y, Sahara Y, Hosokawa Y, Murakami Y, Yamaue H, Satoi S, Unno M, Isaji S, Endo I, Sho M, Fujii T, Takishita C, Hijikata Y, Suzuki S, Kawachi S, Katsumata K, Ohta T, Nagakawa T, Tsuchida A.
-
Journal Title
Ann Surg Oncol.
Volume: in press
Issue: 6
Pages: 1629-1636
DOI
Related Report
Peer Reviewed
-
[Journal Article] Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).2019
Author(s)
Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M, Honda G, Matsumoto I, Wada K, Furuse J, Matsuyama Y, Unno M; Study Group of Preoperative Therapy for Pancreatic Cancer (Prep) and Japanese Study Group of Adjuvant Therapy for Pancreatic cancer (JSAP).
-
Journal Title
Jpn J Clin Oncol.
Volume: 49
Issue: 2
Pages: 190-194
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic Recurrence in Patients with Curatively Resected Pancreatic Adenocarcinoma.2019
Author(s)
Motoi F, Murakami Y, Okada KI, Matsumoto I, Uemura K, Satoi S, Sho M, Honda G, Fukumoto T, Yanagimoto H, Kinoshita S, Kurata M, Aoki S, Mizuma M, Yamaue H, Unno M; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS).
-
Journal Title
World J Surg.
Volume: 43
Issue: 2
Pages: 634-641
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma2018
Author(s)
Hirono S, Kawai M, Okada KI, Fujii T, Sho M, Satoi S, Amano R, Eguchi H, Mataki Y, Nakamura M, Matsumoto I, Baba H, Tani M, Kawabata Y, Nagakawa Y, Yamada S, Murakami Y, Shimokawa T, Yamaue H.
-
Journal Title
Trials
Volume: 19
Issue: 1
Pages: 613-613
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD.2018
Author(s)
Maeda H, Okada KI, Fujii T, Oba MS, Kawai M, Hirono S, Kodera Y, Sho M, Akahori T, Shimizu Y, Ambo Y, Kondo N, Murakami Y, Ohuchida J, Eguchi H, Nagano H, Sakamoto J, Yamaue H.
-
Journal Title
Oncol Lett.
Volume: 16
Pages: 6847-6853
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Outcomes of 1,639 hepatectomies for non-colorectal non-neuroendocrine liver metastases: a multicenter analysis.2018
Author(s)
Sano K, Yamamoto M, Mimura T, Endo I, Nakamori S, Konishi M, Miyazaki M, Wakai T, Nagino M, Kubota K, Unno M, Sata N, Yamamoto J, Yamaue H, Takada T; Japanese Society of Hepato-Biliary-Pancreatic Surgery.
-
Journal Title
J Hepatobiliary Pancreat Sci.
Volume: 25
Issue: 11
Pages: 465-475
DOI
Related Report
Peer Reviewed
-
[Journal Article] Learning curve and surgical factors influencing the surgical outcomes during the initial experience with laparoscopic pancreaticoduodenectomy.2018
Author(s)
Nagakawa Y, Nakamura Y, Honda G, Gotoh Y, Ohtsuka T, Ban D, Nakata K, Sahara Y, Velasquez VVDM, Takaori K, Misawa T, Kuroki T, Kawai M, Morikawa T, Yamaue H, Tanabe M, Mou Y, Lee WJ, Shrikhande SV, Conrad C, Han HS, Tang CN, Palanivelu C, Kooby DA, Asbun HJ, Wakabayashi G, Tsuchida A, Takada T, Yamamoto M, Nakamura M.
-
Journal Title
J Hepatobiliary Pancreat Sci.
Volume: 25
Issue: 11
Pages: 498-507
DOI
Related Report
Peer Reviewed
-
[Journal Article] Intensive perioperative rehabilitation improves surgical outcomes after pancreaticoduodenectomy2018
Author(s)
Kitahata Y, Hirono S, Kawai M, Okada KI, Miyazawa M, Shimizu A, Kobayashi R, Ueno M, Hayami S, Shimokawa T, Kouda K, Tajima F, Yamaue H.
-
Journal Title
Langenbeck's Archives of Surgery
Volume: 403
Issue: 6
Pages: 711-718
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
[Journal Article] Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer.2018
Author(s)
Hayata K, Ojima T, Nakamori M, Nakamura M, Katsuda M, Kitadani J, Takeuchi A, Tabata H, Maruoka S, Yamaue H.
-
Journal Title
Anticancer Research
Volume: 38
Issue: 9
Pages: 5267-5273
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Difficulty scoring system in laparoscopic distal pancreatectomy.2018
Author(s)
Ohtsuka T, Ban D, Nakamura Y, Nagakawa Y, Tanabe M, Gotoh Y, Velasquez VVDM, Nakata K, Sahara Y, Takaori K, Honda G, Misawa T, Kawai M, Yamaue H, Morikawa T, Kuroki T, Mou Y, Lee WJ, Shrikhande SV, Tang CN, Conrad C, Han HS, Palanivelu C, Asbun HJ, Kooby DA, Wakabayashi G, Takada T, Yamamoto M, Nakamura M.
-
Journal Title
J Hepatobiliary Pancreat Sci.
Volume: 25
Issue: 11
Pages: 489-497
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
[Journal Article] Splenic vein resection together with the pancreatic parenchyma versus separated resection after isolation of the parenchyma during distal pancreatectomy (COSMOS-DP trial): study protocol for a randomised controlled trial2018
Author(s)
Yamada S, Fujii T, Kawai M, Shimokawa T, Nakamura M, Murakami Y, Satoi S, Eguchi H, Nagakawa Y, Kodera Y, Yamaue H.
-
Journal Title
Trials
Volume: 19
Issue: 1
Pages: 369-369
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Clinical impact of developing better practices at the institutional level on surgical outcomes after distal pancreatectomy in 1515 patients: Domestic audit of the Japanese Society of Pancreatic Surgery.2018
Author(s)
Satoi S, Yamamoto T, Motoi F, Matsumoto I, Yoshitomi H, Amano R, Tahara M, Murakami Y, Arimitsu H, Hirono S, Sho M, Ryota H, Ohtsuka M, Unno M, Takeyama Y, Yamaue H.
-
Journal Title
Ann Gastroenterol Surg.
Volume: 25
Issue: 3
Pages: 212-219
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers.2018
Author(s)
Furuta M, Tanaka H, Shiraishi Y, Unida T, Imamura M, Fujimoto A, Fujita M, Sasaki-Oku A, Maejima K, Nakano K, Kawakami Y, Arihiro K, Aikata H, Ueno M, Hayami S, Ariizumi SI, Yamamoto M, Gotoh K, Ohdan H, Yamaue H, Miyano S, Chayama K, Nakagawa H.
-
Journal Title
Oncotarget.
Volume: 9
Issue: 38
Pages: 25075-25088
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
[Journal Article] Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients.2017
Author(s)
Miyazawa M, Katsuda M, Maguchi H, Katanuma A, Ishii H, Ozaka M, Yamao K, Imaoka H, Kawai M, Hirono S, Okada KI, Yamaue H.
-
Journal Title
Int J Cancer.
Volume: 140
Issue: 4
Pages: 973-982
DOI
Related Report
Peer Reviewed
-
[Journal Article] Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a first-line treatment in patients with unresectable advanced pancreatic cancer.2017
Author(s)
Yamaue H, Shimizu A, Hagiwara Y, Sho M, Yanagimoto H, Nakamori S, Ueno H, Ishii H, Kitano M, Sugimori K, Maguchi H, Ohkawa S, Imaoka H, Hashimoto D, Ueda K, Nebiki H, Nagakawa T, Isayama H, Yokota I, Ohashi Y, Shirasaka T.
-
Journal Title
Cancer Chemother Pharmacol.
Volume: in press
Issue: 4
Pages: 813-823
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-